Neurochlore Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 3

Neurochlore General Information

Description

Developer of a neuro-therapeutic treatment platform intended to treat autism spectrum disorders. The company's platform develops new therapeutic approaches to ameliorate neurological and psychiatric diseases based on the regulation of the brain's electrical activity around a wide range of animal models of ASD and syndromes with associated autism, enabling patients to modulate intracellular chloride.

Contact Information

Website
www.neurochlore.fr
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 163 Avenue de Luminy
  • Zone Luminy Biotech, Case 922, Cedex 09
  • 13273 Marseille
  • France
Primary Industry
Drug Discovery
Vertical(s)
LOHAS & Wellness, TMT, HealthTech
Corporate Office
  • 163 Avenue de Luminy
  • Zone Luminy Biotech, Case 922, Cedex 09
  • 13273 Marseille
  • France

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neurochlore Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private 01-Aug-2022 00.000 Completed Clinical Trials - Phase 3
3. Early Stage VC 18-Jul-2013 00.000 00.000 00.00 Completed Startup
2. Accelerator/Incubator Completed Startup
1. Grant 12-Nov-2012 Completed Startup
To view Neurochlore’s complete valuation and funding history, request access »

Neurochlore Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A Preferred 0,000 000.000000 00000.00 00000.00 00 00000.00 00.000
Ordinary 000 000.000000 000.00 000.00 00 000.00 0.000
To view Neurochlore’s complete cap table history, request access »

Neurochlore Patents

  • 13

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 8

    Granted

  • 3

    Pending

  • 000

    Expiring in next 12 mo

Neurochlore Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220370390-A1 Liquid oral formulation of bumetanide Pending 31-Oct-2019 0000000000
EP-4051232-A1 Liquid oral formulation of bumetanide Pending 31-Oct-2019 0000000000
CA-3158575-A1 Liquid oral formulation of bumetanide Pending 31-Oct-2019 0000000000
EP-2808391-A1 Modulators of intracellular chloride concentration for treating neurodegenerative diseases with parkinsonian syndromes Inactive 31-May-2013 0000000000 0
US-10201507-B2 Modulators of intracellular chloride concentration for treating fragile x syndrome Active 16-Nov-2012 A61K31/00 00
To view Neurochlore’s complete patent history, request access »

Neurochlore Executive Team (5)

Name Title Board Seat
Constance Ben-Ari General Manager
Eric Lemonnier Ph.D Co-Founder
Nouchine Hadjikhani Ph.D Co-Founder
Yehezkel Ben-Ari Ph.D Co-Founder, Co-Chief Executive Officer, President & Board Member
You’re viewing 4 of 5 executive team members. Get the full list »

Neurochlore Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
L'Agence Nationale de la Recherche Government 000 0000 000000 0
Grand Luminy Corporation Minority 000 0000 000000 0
Incubateur Impulse Accelerator/Incubator 000 0000 000000 0
To view Neurochlore’s complete investors history, request access »

Ready to get started?

Request a free trial

Neurochlore FAQs

  • When was Neurochlore founded?

    Neurochlore was founded in 2011.

  • Who is the founder of Neurochlore?

    Denis Ravel Ph.D, Eric Lemonnier Ph.D, Nouchine Hadjikhani Ph.D, and Yehezkel Ben-Ari Ph.D are the founders of Neurochlore.

  • Who is the CEO of Neurochlore?

    Yehezkel Ben-Ari Ph.D is the CEO of Neurochlore.

  • Where is Neurochlore headquartered?

    Neurochlore is headquartered in Marseille, France.

  • What industry is Neurochlore in?

    Neurochlore’s primary industry is Drug Discovery.

  • Is Neurochlore a private or public company?

    Neurochlore is a Private company.

  • What is Neurochlore’s current revenue?

    The current revenue for Neurochlore is 000000.

  • How much funding has Neurochlore raised over time?

    Neurochlore has raised $1.97M.

  • Who are Neurochlore’s investors?

    L'Agence Nationale de la Recherche, Grand Luminy, and Incubateur Impulse have invested in Neurochlore.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »